Company intelligence / Profile preview
Octagon Therapeutics
Providence, Rhode Island, United Statesoctagontherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Octagon Therapeutics was a biotech company focused on developing novel medicines for autoimmune and inflammatory diseases by restoring the function of immune checkpoints using glycoproteome insights. The company deprioritized its lead B cell immunomodulator program due to unresolved biology questions and ultimately decided to wind down operations in April 2025. Its most advanced asset was preclinical.
- Therapeutic areas
- ImmunologyCardiovascular
- Modalities
- Small molecules (inferred from drug development focus and typical approaches for immune checkpoint modulation)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Novo Nordisk – research alliance formed in 2022, including participation in Novo’s Co-Creation Greenhouse accelerator program focused on cardiometabolic disease targets.
Beyond the preview
Go deeper on Octagon Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Octagon Therapeutics.